Pfizer COVID-19 vaccine 93% effective at preventing pediatric hospitalizations
Two doses of the Pfizer vaccine are 93% effective at preventing COVID-19 hospitalization among children aged 12 to 18, according to a study at 19 pediatric hospitals released today by the Centers for Disease Control and Prevention. The study examined prior vaccination status among 464 patients hospitalized with and without COVID-19 between June and September, when the delta variant was predominant, and found nearly all (97%) of the patients hospitalized with COVID-19 were unvaccinated. The authors said the findings “reinforce the importance of vaccination to protect U.S. youths against severe COVID-19.” The Pfizer vaccine is currently the only COVID-19 vaccine authorized for this age group.
Related News Articles
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…